Similar articles

• Calcium channel blockers versus angiotensin-converting enzyme inhibitors: renal effects.

  Linas S. Linas S. Am J Kidney Dis. 1990 Oct;16(4 Suppl 1):15-9. Am J Kidney Dis. 1990. PMID: 2220796 Review.
• Comparison of the effects of ACE inhibitors and calcium channel blockers on the progression of renal failure.

  Zucchelli P, Zuccalà A, Gaggi R. Zucchelli P, et al. Nephrol Dial Transplant. 1995 Oct;10 Suppl 9:46-51. Nephrol Dial Transplant. 1995. PMID: 8643208 Clinical Trial. No abstract available.
• Protecting the kidney in hypertension.

  Weinberg MS, Cottiero RA, Yoburn DC. Weinberg MS, et al. R I Med. 1993 May;76(5):225-8. R I Med. 1993. PMID: 8518496 Review. No abstract available.
• Effects of felodipine in patients with refractory hypertension and progressive renal disease.

  Herlitz H, Nyberg G, Granérus G, Björck S, Aurell M. Herlitz H, et al. Scand J Urol Nephrol Suppl. 1988;108:31-4. Scand J Urol Nephrol Suppl. 1988. PMID: 3163828 No abstract available.
• Converting enzyme inhibitors and calcium antagonists in the long-term treatment of hypertension in chronic renal failure.

  Lenz T, August P. Lenz T, et al. Wien Klin Wochenschr. 1990 May 25;102(11):315-9. Wien Klin Wochenschr. 1990. PMID: 2195780 Review.